Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359

Benzinga · 2d ago
Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $362 to $359.